SUPERNUS PHARMACEUTICALS, INC. Available-for-sale Securities
SUPERNUS PHARMACEUTICALS, INC. (SUPN) had Available-for-sale Securities of $173.37 million as of 2017-12-31, per its 10-K filed 2018-03-01.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecurities · last filed 2018-03-01
- 2017-12-31: Available-for-sale Securities $173.37M.
- 2017-09-30: Available-for-sale Securities $155.75M.
- 2017-06-30: Available-for-sale Securities $135.86M.
- 2017-03-31: Available-for-sale Securities $116.70M.
| Period end | Available-for-sale Securities | Available-for-sale Securities as first filed |
|---|---|---|
| 2017-12-31 | $173.37M 10-K · filed 2018-03-01 | |
| 2017-09-30 | $155.75M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $135.86M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $116.70M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $99.13M 10-K · filed 2018-03-01 | |
| 2016-09-30 | $93.07M 10-Q · filed 2017-01-20 | |
| 2016-06-30 | $91.87M 10-Q/A · filed 2017-01-23 | |
| 2016-03-31 | $94.22M 10-Q/A · filed 2017-01-20 | |
| 2015-12-31 | $83.70M 10-K · filed 2017-03-16 | $83.05M 10-K · filed 2016-03-09 |
| 2015-09-30 | $76.03M 10-Q/A · filed 2017-01-20 | $75.38M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $70.82M 10-Q/A · filed 2017-01-23 | $70.17M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $66.99M 10-Q/A · filed 2017-01-20 | $66.34M 10-Q · filed 2015-05-06 |
| 2014-12-31 | $57.76M 10-Q/A · filed 2017-01-20 | |
| 2014-09-30 | $50.55M 10-Q/A · filed 2017-01-20 | |
| 2014-06-30 | $50.78M 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $58.28M 10-Q · filed 2014-05-13 | |
| 2013-12-31 | $57.97M 10-K · filed 2015-03-12 | |
| 2012-12-31 | $48.21M 10-K · filed 2014-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |